New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 29, 2012
08:15 EDTTKMRTekmira Pharmaceuticals acquires worldwide license to novel RNAi Technology
Tekmira Pharmaceuticals announced that it has obtained a worldwide, non-exclusive license to a novel RNAi payload technology called Unlocked Nucleobase Analog, or UNA, from Marina Biotech, for the development of RNAi therapeutics. UNA technology can be used in the development of RNAi therapeutics, which treat disease by silencing specific disease causing genes. UNAs can be incorporated into RNAi drugs and have the potential to improve them by increasing their stability and reducing off-target effects.
News For TKMR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 25, 2015
13:57 EDTTKMRUK nurse make full recovery from Ebola, WSJ says
Subscribe for More Information
January 23, 2015
10:07 EDTTKMRHigh option volume stocks
High option volume stocks: CE TSM RYAM NOC SNE FXCM LBTYA TKMR LF STT
January 22, 2015
16:41 EDTTKMRFalcon Edge Capital reports 9/9% passive stake in Tekmira
Subscribe for More Information
09:54 EDTTKMRTekmira mentioned cautiously by TheStreetSweeper
Subscribe for More Information
January 21, 2015
08:34 EDTTKMRTekmira initiates Phase I clinical trial of TKM-HBV
Subscribe for More Information
January 20, 2015
17:09 EDTTKMRRA Capital reports 9.9% passive stake in Tekmira
Subscribe for More Information
January 19, 2015
12:06 EDTTKMRNeurovive: Merger between Oncore and Tekmira includes NVP018 development
Subscribe for More Information
January 13, 2015
10:00 EDTTKMROn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:07 EDTTKMRTekmira price target raised to $35 from $25 at RBC Capital
Subscribe for More Information
07:09 EDTTKMRTekmira upgraded to Outperform from Market Perform at Leerink
Leerink upgraded Tekmira to Outperform with a $30 price target citing the company's merger with OnCore.
January 12, 2015
11:14 EDTTKMRDenver patient being tested for Ebola, KUSA-TV reports
A patient recently returned from Ebola affected areas in Africa is being tested in Denver for the disease, reported local NBC affiliate 9New KUSA-TV. Drug companies that are working on experimental Ebola vaccines or treatments include Peregrine (PPHM), Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Some companies that offer protective clothing and waste disposal include Lakeland Industries (LAKE) and Alpha Pro Tech (APT). Reference Link
10:06 EDTTKMRHigh option volume stocks
Subscribe for More Information
06:15 EDTTKMRTekmira to host conference call
Conference call to discuss merger agreement with OnCore Biopharma will be held on January 12 at 8:30 am. Webcast Link
05:09 EDTTKMRTekmira, OnCore Biopharma announce merger agreement
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use